Literature DB >> 8641972

A quantitative trait locus in major histocompatibility complex determining latent period of mouse lymphomas.

T Kamoto1, H Shisa, A Pataer, L Lu, O Yoshida, Y Yamada, H Hiai.   

Abstract

The effects of two host genes on retrovirus-induced murine lymphoma were evaluated by studying 114 F2 intercross mice between SL/Kh and AKR/Ms mice. Out of 47 T-lymphoma-bearing F2 mice, 45 had the AKR-derived dominant allele at Tism-1. The length of the lymphoma latent period was not related to type of tumor. Instead, it was significantly shortened by a recessive SL/Kh-derived allele at a major histocompatibility complex (MHC)-linked locus on Chr. 17. A quantitative trait analysis of the latent period yielded a maximal logarithm of likelihood ratio for linkage (LOD) score of 7.06 at a class II gene within MHC. The SL/Kh-derived recessive gene was named lla (lymphoma latency acceleration).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641972      PMCID: PMC5921108          DOI: 10.1111/j.1349-7006.1996.tb00236.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


major histocompatibility complex polymerase chain reaction analysis of variance linkage disequilibrium quantitative trait locus logarithm of likelihood ratio for linkage
  19 in total

1.  Influence of MHC genes on spontaneous recovery from Friend retrovirus-induced leukemia.

Authors:  M Miyazawa; J Nishio; K Wehrly; B Chesebro
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

2.  The origin of SL family mice.

Authors:  P Abujiang; Y Yamada; O Haller; H Kobayashi; T Kamoto; L M Lu; M Ogawa; A Ishimoto; H Katoh; K Kanehira; S Ikegami; M Fukumoto; H Hiai
Journal:  Lab Anim Sci       Date:  1996-08

3.  SL/KH strain of mice: a model of spontaneous pre-B-lymphomas.

Authors:  M O Shimada; Y Yamada; Y Nakakuki; K Okamoto; M Fukumoto; T Honjo; H Hiai
Journal:  Leuk Res       Date:  1993-07       Impact factor: 3.156

Review 4.  The H-2 complex regulates both the susceptibility to mouse viral lymphomagenesis and the phenotype of the virus-induced lymphomas.

Authors:  M Zijlstra; W L Vasmel; T Radaskiewicz; E Matthews; C J Melief
Journal:  J Immunogenet       Date:  1986 Apr-Jun

5.  Rfv-1 and Rfv-2, two H-2-associated genes that influence recovery from Friend leukemia virus-induced splenomegaly.

Authors:  B Chesebro; K Wehrly
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

6.  Progression of mouse thymic leukemias in thymic microenvironments.

Authors:  H Hiai; H Kaneshima; Y Nishi; Y Nishizuka
Journal:  Princess Takamatsu Symp       Date:  1983

7.  Genetic resistance to murine leukemia induced by different radiation leukemia virus variants; a comparative study on the role of the H-2 complex.

Authors:  P Lonai; N Haran-Ghera
Journal:  Immunogenetics       Date:  1980-07       Impact factor: 2.846

8.  Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains.

Authors:  W H Berrettini; T N Ferraro; R C Alexander; A M Buchberg; W H Vogel
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

9.  MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations.

Authors:  E S Lander; P Green; J Abrahamson; A Barlow; M J Daly; S E Lincoln; L A Newberg; L Newburg
Journal:  Genomics       Date:  1987-10       Impact factor: 5.736

10.  The effect of histocompatibility-2 type on response to friend leukemia virus in mice.

Authors:  F Lilly
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  2 in total

1.  Propylnitrosourea-induced T-lymphomas in LEXF RI strains of rats: genetic analysis.

Authors:  L M Lu; H Shisa; J Tanuma; H Hiai
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

2.  Quantitative trait loci associated with promoting effects of sodium L-ascorbate on two-stage bladder carcinogenesis in rats.

Authors:  T Kamoto; S Mori; T Murai; Y Yamada; S Makino; O Yoshida; H Hiai
Journal:  Jpn J Cancer Res       Date:  1997-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.